Jenna Gonzales
Acute Care · Phoenix, AZNPI 1275048357
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Cvrx, Inc. accounts for 63.4% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $3,997 and has fallen 54.4% since, to $1,823 in 2025. Among acute care clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $100.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cvrx, Inc.$5K
- Penumbra, Inc.$2K
- Abbott$181
- Atricure, Inc.$160
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$151
- Abiomed$150
- plus $582 from 10 others
What the payments were for
- Consulting fees$1,20014%
- Travel & lodging$2,20126%
- Food & beverage$4,93959%
- Education$260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cvrx, Inc. | 57 | $5,303 |
| Penumbra, Inc. | 7 | $1,840 |
| Abbott | 2 | $181 |
| Atricure, Inc. | 1 | $160 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $151 |
| Abiomed | 1 | $150 |
| Inspire Medical Systems, Inc. | 1 | $150 |
| Kestra Medical Technology Services, Inc. | 1 | $150 |
| ZOLL Respicardia, Inc. | 1 | $142 |
| Biosense Webster, Inc. | 1 | $30 |
| Merck | 1 | $26 |
| Philips North America LLC | 1 | $22 |
| Novo Nordisk | 1 | $19 |
| Lilly USA, LLC | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barostim Neo System$4,123
- Indigo System$1,673
- ATRICLIP LAA EXCLUSION SYSTEM$160
- Impella$150
- Inspire$150
- Assure WCD$150
- MitraClip$145
- remede System$142
- LifeVest$127
How this compares
$8,366 in reported general payments places this provider in the 95th percentile of 482 acute care providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 57 | $63,963 |
| BrilintaTicagrelor | 18 | $21,525 |
| Repatha SureclickEvolocumab | 12 | $16,165 |
| FarxigaDapagliflozin Propanediol | 12 | $13,380 |
| Praluent PenAlirocumab | 14 | $10,763 |
| Ranolazine ErRanolazine | 18 | $1,895 |
| ClopidogrelClopidogrel Bisulfate | 92 | $1,207 |
| Potassium Chloride | 76 | $1,149 |
| Atorvastatin Calcium | 95 | $926 |
| Losartan Potassium | 75 | $851 |
| Metoprolol Tartrate | 127 | $654 |
| Rosuvastatin Calcium | 58 | $639 |
| Metoprolol Succinate | 34 | $494 |
| Spironolactone | 51 | $493 |
| Carvedilol | 48 | $469 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta, Farxiga | $14 | $34,90530 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 482 acute care providers in Arizona.
Other acute care in Phoenix
- Kim KrmpoticPhoenix$79K
- Laura Cook-GongoraPhoenix$32K
- Cathy PaynePhoenix$26K
- Chandra SorrellePhoenix$16K
- Nicole RauscherPhoenix$12K
- Brooke GambinoPhoenix$11K
- Kelly WesselhoffPhoenix$9K
- Kristen HudsonPhoenix$8K
- Tammy TyreePhoenix$8K
- Lydia ChongPhoenix$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.